Content about Collaborative Care

December 12, 2012

GlaxoSmithKline is sponsoring a national campaign to investigate ways to build healthier communities in the United States and has made its latest stop, in St. Louis, the company said Wednesday.

ST. LOUIS — GlaxoSmithKline is sponsoring a national campaign to investigate ways to build healthier communities in the United States and has made its latest stop, in St. Louis, the company said Wednesday.

December 12, 2012

A subsidiary of Johnson & Johnson is seeking regulatory approval for a new Type 2 diabetes drug.

RARITAN, N.J. — A subsidiary of Johnson & Johnson is seeking regulatory approval for a new Type 2 diabetes drug.

J&J division Janssen Research & Development announced Wednesday that it had filed with the Food and Drug Administration for a drug combining the experimental drug canagliflozin and immediate-release metformin, a common generic drug for diabetes.

The company also submitted a regulatory approval application to the FDA for canagliflozin in May 2012.

December 12, 2012

A national group representing state boards of pharmacy has announced its support for efforts to strengthen regulations on compounding pharmacies.

MOUNT PROSPECT, Ill. — A national group representing state boards of pharmacy has announced its support for efforts to strengthen regulations on compounding pharmacies.

The National Association of Boards of Pharmacy said Wednesday that it would implement a four-part action plan centered around inspection of compounding pharmacies and sharing data from the inspections among boards of pharmacies around the country.

December 12, 2012

The mail-order pharmacy business of pharmacy benefit manager Prime Therapeutics has received accreditation from the Washington-based healthcare accrediting organization URAC, Prime said Wednesday.

ST. PAUL, Minn. — The mail-order pharmacy business of pharmacy benefit manager Prime Therapeutics has received accreditation from the Washington-based healthcare accrediting organization URAC, Prime said Wednesday.

Prime received its first mail-service pharmacy accreditation on Jan. 1, 2009, and will remain accredited through Jan. 1, 2016, the company said.

December 12, 2012

Thousands of patients in Los Angeles with serious, chronic diseases could soon find themselves unable to get their drugs from community pharmacies, advocates for the pharmacies said.

NEW YORK — Thousands of patients in Los Angeles with serious, chronic diseases could soon find themselves unable to get their drugs from community pharmacies, advocates for the pharmacies said.

December 12, 2012

More than 10% of Americans consider Web-enabled, mobile health apps a part of their health care and key to living long lives, according to a new survey by a division of electronics manufacturer Philips.

ANDOVER, Mass. — More than 10% of Americans consider Web-enabled, mobile health apps a part of their health care and key to living long lives, according to a new survey by a division of electronics manufacturer Philips.

Royal Philips Electronics commissioned Opinion Research to conduct a survey of 1,003 adults, finding that 11% said that were it not for Web-based health information, they might already be "dead or severely incapacitated."

December 12, 2012

Xenon Pharmaceuticals is licensing an experimental pain drug to Teva Pharmaceutical Industries in a deal worth up to $376 million, the companies said.

JERUSALEM — Xenon Pharmaceuticals is licensing an experimental pain drug to Teva Pharmaceutical Industries in a deal worth up to $376 million, not including royalties, the companies said.

December 12, 2012

Drug maker ViroPharma has launched an education campaign focused on a rare, debilitating and life-threatening genetic disorder.

EXTON, Pa. — Drug maker ViroPharma has launched an education campaign focused on a rare, debilitating and life-threatening genetic disorder.

The company announced Wednesday the launch of the unbranded campaign focused on hereditary angioedema, particularly the emotional and psychological burden faced by patients with the disease, which results from deficiency of the human plasma protein C1 inhibitor and causes attacks of swelling and pain.

December 11, 2012

Biotech and vaccines company Nuron Biotech has bought rights from Pfizer for a vaccine to prevent infection by a bacteria that is a major cause of infectious disease around the world.

EXTON, Pa. — Biotech and vaccines company Nuron Biotech has bought rights from Pfizer for a vaccine to prevent infection by a bacteria that is a major cause of infectious disease around the world.

December 11, 2012

The Food and Drug Administration is allowing a drug made by Eisai for treating gastroesophageal reflux disease to retain its market exclusivity for six months past the original expiration date, the company said.

WOODCLIFF LAKE, N.J. — The Food and Drug Administration is allowing a drug made by Eisai for treating gastroesophageal reflux disease to retain its market exclusivity for six months past the original expiration date, the company said Tuesday.

Eisai said the FDA had granted six more months of exclusivity for the use of Aciphex (rabreprazole sodium) in children, meaning it will lose market exclusivity on Nov. 8, 2013.

December 11, 2012

The consumer healthcare division of drug maker GlaxoSmithKline has launched a new website designed to encourage people to quit smoking and promote such products as nicotine gums, lozenges and patches.

PARSIPPANY, N.J. — The consumer healthcare division of drug maker GlaxoSmithKline has launched a new website designed to encourage people to quit smoking and promote such products as nicotine gums, lozenges and patches.

Quit.com is described as a "total quit-smoking online resource" that includes features to help smokers create personalized plans for quitting without relapsing.

December 11, 2012

The Supreme Court will review settlements between branded and generic drug companies that critics say delay patients' access to cheaper drug treatments, according to published reports.

NEW YORK — The Supreme Court will review settlements between branded and generic drug companies that critics say delay patients' access to cheaper drug treatments, according to published reports.

Politico reported that the justices had agreed to hear three cases, including Federal Trade Commission v. Watson Pharmaceuticals, involving settlements between branded and generic drug companies that critics deride as "pay-for-delay" deals.

December 10, 2012

The American Heart Association has joined a group of patient and provider organizations promoting safe use of a commonly used class of painkillers.

EUGENE, Ore. — The American Heart Association has joined a group of patient and provider organizations promoting safe use of a commonly used class of painkillers.

The AHA announced that it had joined the Alliance for the Rational Use of NSAIDs, which refers to nonsteroidal anti-inflammatory drugs, a class that includes the common drug ibuprofen. Other members include the American Academy of Nurse Practitioners and the American Association of Colleges of Pharmacy.

December 10, 2012

Amgen is buying an Iceland-based biotech company for $415 million, the two said Monday.

THOUSAND OAKS, Calif. — Amgen is buying an Iceland-based biotech company for $415 million, the two said Monday.

Amgen announced it would acquire DeCode Genetics, based in Reykjavik, Iceland, in a deal that Amgen's board of directors unanimously approved. Founded in 1996, DeCode focuses its business on finding links between the human genome and disease susceptibility. The acquisition is expected to close before the end of 2012 and does not require regulatory approval.

December 10, 2012

The Food and Drug Administration has approved a new use for a cancer drug made by Johnson & Johnson, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new use for a cancer drug made by Johnson & Johnson, the agency said Monday.

The FDA announced the approval of Zytiga (abiraterone acetate), made by J&J subsidiary Janssen Biotech, for men with castration-resistant prostate cancer that has spread to other parts of the body, for use prior to receiving chemotherapy. The drug was already approved for castration-resistant prostate cancer in men who had already undergone chemotherapy treatment.

December 10, 2012

Several stores in the Giant Food Stores chain will collect used respiratory inhalers under a program sponsored by drug maker GlaxoSmithKline, the supermarket chain said.

CARLISLE, Pa. — Several stores in the Giant Food Stores chain will collect used respiratory inhalers under a program sponsored by drug maker GlaxoSmithKline, the supermarket chain said.

Giant, an Ahold-owned banner also known as Giant-Carlisle to distinguish it from fellow Ahold banner Giant Food of Landover, Md., said 48 stores in Pennsylvania would participate in GSK's "Complete the Cycle" recycle program for respiratory inhalers used to treat asthma, chronic obstructive pulmonary disease, allergies and flu.

December 10, 2012

A Congressional committee is looking into allegations that a compounding pharmacy industry association may have taught pharmacists how to sidestep requests for samples from the Food and Drug Administration, according to published reports.

NEW YORK — A Congressional committee is looking into allegations that a compounding pharmacy industry association may have taught pharmacists how to sidestep requests for samples from the Food and Drug Administration, according to published reports.

Reuters reported that the House Energy and Commerce Committee had requested internal documents from the International Academy of Compounding Pharmacists, citing a news report about the organization.

December 7, 2012

AffordRx.com is making a prescription discount card that offers savings of up to 75% at more than 56,000 pharmacies across the country available to all residents of the United States, the company said.

DALLAS — AffordRx.com is making a prescription discount card that offers savings of up to 75% at more than 56,000 pharmacies across the country available to all residents of the United States, the company said.

The company said the cards would be available without restrictions on membership and that there were no income requirements, age limitations or applications.

"We are excited to launch this program, potentially saving Americans millions of dollars on their prescription medication," AffordRx spokesman Dylan Marc said.

December 7, 2012

Inc. magazine has named Diplomat Specialty Pharmacy as one of the country's top 100 job creators, the privately owned company said.

FLINT, Mich. — Inc. magazine has named Diplomat Specialty Pharmacy as one of the country's top 100 job creators, the privately owned company said.

December 7, 2012

The state health department in Massachusetts has made changes to the state's pharmacy board and leveled sanctions against three pharmacies in the wake of a nationwide meningitis outbreak traced to a compounding pharmacy in the state, the department said.

BOSTON — The state health department in Massachusetts has made changes to the state's pharmacy board and leveled sanctions against three pharmacies in the wake of a nationwide meningitis outbreak traced to a compounding pharmacy in the state, the department said.

December 7, 2012

The Food and Drug Administration has approved a generic hypertension drug made by Mylan, the company said.

PITTSBURGH — The Food and Drug Administration has approved a generic hypertension drug made by Mylan, the company said.

Mylan announced the approval and launch of candesartan cilexetil and hydrochlorothiazide tablets in the 16/12.5-mg, 32/12.5-mg and 32/25-mg strengths. Mylan said it was the first company to submit a complete regulatory approval application for the drug and is thus entitled to 180 days of market exclusivity in which to compete directly with the branded version.

December 6, 2012

Pharmacy benefit manager Catamaran Corp. has opened a new "Center of Excellence" in downtown Indianapolis, the company said Thursday.

LISLE, Ill. — Pharmacy benefit manager Catamaran Corp. has opened a new "Center of Excellence" in downtown Indianapolis, the company said Thursday.

Catamaran announced the opening of the 13,000-square-foot center, which it said will support the services it will provide under the $60 million, six-year Medicaid contract with the Indiana state government, signed in October.

December 6, 2012

The Food and Drug Administration has given special designation to a treatment made by Biodel for patients with congenital hyperinsulinism, a rare disorder that affects children.

DANBURY, Conn. — The Food and Drug Administration has given special designation to a treatment made by Biodel for patients with congenital hyperinsulinism, a rare disorder that affects children.

Biodel announced that it had received orphan drug designation for glucagon to prevent hypoglycemia, or abnormally low blood sugar, in patients with CHI.

December 6, 2012

Johnson & Johnson is seeking approval from the Food and Drug Administration for a drug to treat active psoriatic arthritis, the company said Thursday.

HORSHAM, Pa. — Johnson & Johnson is seeking approval from the Food and Drug Administration for a drug to treat active psoriatic arthritis, the company said Thursday.

J&J subsidiary Janssen Biotech submitted an application to the FDA for Stelara (ustekinumab) for adult patients with the disease, which affects more than 2 million people in the United States, according to the National Psoriasis Foundation. Another subsidiary is seeking approval for Stelara for the same usage in Europe.

December 6, 2012

Par Pharmaceutical Cos. has contracted with AstraZeneca to distribute an authorized generic version of a drug used to treat high blood pressure, Par said.

WOODCLIFF LAKE, N.J. — Par Pharmaceutical Cos. has contracted with AstraZeneca to distribute an authorized generic version of a drug used to treat high blood pressure, Par said.

Par announced that it had entered a supply and distribution agreement through subsidiary Par Pharmaceutical to distribute an authorized generic version of Atacand HCT (i.e., candesartan cilexetil and hydrochlorothiazide) tablets.

An authorized generic is a branded drug marketed under its generic name at a discounted price, usually through a third-party company.